LexaGene (CVE:LXG) Trading Down 19.2% – Here’s What Happened

LexaGene Holdings Inc. (CVE:LXG)’s share price dropped 19.2% during trading on Friday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.

LexaGene Stock Down 19.2 %

The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39. The business’s 50 day moving average price is C$0.11 and its 200 day moving average price is C$0.11. The firm has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.

About LexaGene

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.